Spravato worldwide sales, $ billions

Reported (J&J) 2026 analyst estimate

Spravato worldwide sales: 2022 $374M, 2023 $689M, 2024 $1.08B, 2025 $1.70B, 2026 estimate $2.30B. Monotherapy approved January 2025.

Source: J&J 10-K and quarterly results. 2026 is an analyst/news estimate.